Home > Insider Trading > Filing (0001179110-20-010672)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1697362	Burkes Michael Brophy	C/O Natera, Inc., 201 Industrial Road Suite 410 San Carlos CA 94070	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-10-22	1,626	$10.41	58,503	No	4	M	Direct
Common Stock	Disposition	2020-10-22	1,501	$68.66	57,002	No	4	S	Direct
Common Stock	Disposition	2020-10-22	125	$69.38	56,877	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-10-22	1,626	$0.00	1,626	$10.41

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
17,258		2027-06-08	No	4	M	Direct

Footnotes

The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2019. The Reporting Person is subject to a Lock-up Letter Agreement that expires on November 10, 2020. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.23 to $69.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.25 to $69.55 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These reported shares are subject to restrictions in the Lock-Up Letter Agreement.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter. The exercise of this option is a permissible exemption under the terms of the Lock-Up Letter Agreement.